Letrozole versus tamoxifen in the treatment of advanced breast cancer and as neoadjuvant therapy

By Smith I.E.  

The Journal of Steroid Biochemistry and Molecular Biology, Vol. 86, Iss. 3, 2003-09 ,pp. : 289-293

Elsevier

Access to resources Recommend Favorite

Neoadjuvant tamoxifen and aromatase inhibitors: comparisons and clinical outcomes

By Dixon J.M.   Jackson J.   Renshaw L.   Miller W.R.  

The Journal of Steroid Biochemistry and Molecular Biology, Vol. 86, Iss. 3, 2003-09 ,pp. : 295-299

Elsevier

Access to resources Recommend Favorite

Advanced breast cancer updates on anastrozole versus tamoxifen

By Nabholtz J.M.   Arimidex Study Group  

The Journal of Steroid Biochemistry and Molecular Biology, Vol. 86, Iss. 3, 2003-09 ,pp. : 321-325

Elsevier

Access to resources Recommend Favorite

The relationship between aromatase in primary breast tumors and response to treatment with aromatase inhibitors in advanced disease

By de Jong P.C.   Blankenstein M.A.   Nortier J.W.R.   Slee P.H.T.J.   van de Ven J.   van Gorp J.M.H.H.   Elbers J.R.J.   Schipper M.E.I.   Blijham G.H.   Thijssen J.H.H.   Lu Q.   Jelovac D.   Brodie A.M.  

The Journal of Steroid Biochemistry and Molecular Biology, Vol. 87, Iss. 2, 2003-11 ,pp. : 149-155

Elsevier

Access to resources Recommend Favorite

Celecoxib anti-aromatase neoadjuvant (CAAN) trial for locally advanced breast cancer: preliminary report

By Chow L.W.C.   Wong J.L.N.   Toi M.  

The Journal of Steroid Biochemistry and Molecular Biology, Vol. 86, Iss. 3, 2003-09 ,pp. : 443-447

Elsevier

Access to resources Recommend Favorite